» Articles » PMID: 35042949

The MFF-SIRT1/3 Axis, Regulated by MiR-340-5p, Restores Mitochondrial Homeostasis of Hypoxia-induced Pulmonary Artery Smooth Muscle Cells

Overview
Journal Lab Invest
Specialty Pathology
Date 2022 Jan 19
PMID 35042949
Authors
Affiliations
Soon will be listed here.
Abstract

Mitochondrial dynamics and quality control play a central role in the maintenance of the proliferation-apoptosis balance, which is closely related to the progression of pulmonary arterial hypertension (PAH). However, the exact mechanism of this balance remains unknown. Pulmonary artery smooth muscle cells (PASMCs) were cultured in hypoxia condition for constructing a PAH model in vitro. The expression of genes and proteins were determined by qRT-PCR and western bolt assays. Cell proliferation-apoptosis balance were tested by MTT, EdU and TUNEL assays. The mitochondrial functions were assessed by flow cytometry, JC-1, Mito tracker red staining, and corresponding kits. Besides, the molecular interaction was validated by dual-luciferase reporter assay. MFF was overexpressed in hypoxia-treated PAMSCs. Knockdown of MFF significantly repressed the excessive proliferation but enhanced cell apoptosis in hypoxia-treated PAMSCs. Moreover, MFF silencing improved mitochondrial function of hypoxia-treated PAMSCs by increasing ATP production and decreasing ROS release and mitochondrial fission. Mechanistically, MFF was a directly target of miR-340-5p, and could negatively regulate SIRT1/3 expression. Subsequently, functional rescue assays showed that the biological effects of MFF in hypoxia-treated PAMSCs were negatively regulated by miR-340-5p and depended on the regulation on SIRT1/3 pathway. These results provided evidences that miR-340-5p regulated MFF-SIRT1/3 axis to improve mitochondrial homeostasis and proliferation-apoptosis imbalance of hypoxia-treated PAMSCs, which provided a theoretical basis for the prevention and treatment of PAH.

Citing Articles

The expression and significance of long noncoding RNA XIST/microRNA-340-5p axis and metabolic reprogramming biomarkers in acute cerebrovascular stroke patients: A cross-sectional study.

Elhorany M, El-Horany H, Abd-Ellatif R, Dawood L, Watany M, Basiouny M Medicine (Baltimore). 2025; 103(52):e41092.

PMID: 39969331 PMC: 11688033. DOI: 10.1097/MD.0000000000041092.


High-intensity interval training and moderate-intensity continuous training alleviate vascular dysfunction in spontaneously hypertensive rats through the inhibition of pyroptosis.

Li Y, Luo M, Chang Q, Cao S, Wang Y, Chen Z Heliyon. 2024; 10(21):e39505.

PMID: 39559220 PMC: 11570304. DOI: 10.1016/j.heliyon.2024.e39505.


Emerging insights into pulmonary hypertension: the potential role of mitochondrial dysfunction and redox homeostasis.

Zhang J, Yan H, Wang Y, Yue X, Wang M, Liu L Mol Cell Biochem. 2024; 480(3):1407-1429.

PMID: 39254871 DOI: 10.1007/s11010-024-05096-9.


Mechanisms of cordycepin in the treatment of pulmonary arterial hypertension in rats based on metabonomics and transcriptomics.

Lin J, Chen R, Liao H, Zhang Y, Zheng Z, Hong C Sci Rep. 2024; 14(1):12431.

PMID: 38816406 PMC: 11139979. DOI: 10.1038/s41598-024-62163-3.


Epigenetic regulation of programmed cell death in hypoxia-induced pulmonary arterial hypertension.

Jiang Y, Song S, Liu J, Zhang L, Guo X, Lu J Front Immunol. 2023; 14:1206452.

PMID: 37753070 PMC: 10518698. DOI: 10.3389/fimmu.2023.1206452.


References
1.
Culley M, Chan S . Mitochondrial metabolism in pulmonary hypertension: beyond mountains there are mountains. J Clin Invest. 2018; 128(9):3704-3715. PMC: 6118596. DOI: 10.1172/JCI120847. View

2.
Zhang H, Wang D, Li M, Plecita-Hlavata L, DAlessandro A, Tauber J . Metabolic and Proliferative State of Vascular Adventitial Fibroblasts in Pulmonary Hypertension Is Regulated Through a MicroRNA-124/PTBP1 (Polypyrimidine Tract Binding Protein 1)/Pyruvate Kinase Muscle Axis. Circulation. 2017; 136(25):2468-2485. PMC: 5973494. DOI: 10.1161/CIRCULATIONAHA.117.028069. View

3.
Lopez-Otin C, Blasco M, Partridge L, Serrano M, Kroemer G . The hallmarks of aging. Cell. 2013; 153(6):1194-217. PMC: 3836174. DOI: 10.1016/j.cell.2013.05.039. View

4.
Zhang J, He Z, Fedorova J, Logan C, Bates L, Davitt K . Alterations in mitochondrial dynamics with age-related Sirtuin1/Sirtuin3 deficiency impair cardiomyocyte contractility. Aging Cell. 2021; 20(7):e13419. PMC: 8282250. DOI: 10.1111/acel.13419. View

5.
Guedes-Dias P, Oliveira J . Lysine deacetylases and mitochondrial dynamics in neurodegeneration. Biochim Biophys Acta. 2013; 1832(8):1345-59. DOI: 10.1016/j.bbadis.2013.04.005. View